Authors
Loading...
Randomized trial investigates hepatic lipid metabolism disruptions in mice due to black phosphorus nanomaterials, suggesting biosafety concerns.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: